BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 38510444)

  • 1. Hexosamine biosynthesis and related pathways, protein N-glycosylation and O-GlcNAcylation: their interconnection and role in plants.
    Chen YH; Cheng WH
    Front Plant Sci; 2024; 15():1349064. PubMed ID: 38510444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hexosamine Biosynthesis Pathway: Regulation and Function.
    Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 4. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
    Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
    J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
    Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
    Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
    Akella NM; Ciraku L; Reginato MJ
    BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamine deprivation triggers NAGK-dependent hexosamine salvage.
    Campbell S; Mesaros C; Izzo L; Affronti H; Noji M; Schaffer BE; Tsang T; Sun K; Trefely S; Kruijning S; Blenis J; Blair IA; Wellen KE
    Elife; 2021 Nov; 10():. PubMed ID: 34844667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
    Itano N; Iwamoto S
    Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein O-GlcNAcylation impairment caused by N-acetylglucosamine phosphate mutase deficiency leads to growth variations in Arabidopsis thaliana.
    Jia X; Zhang H; Qin H; Li K; Liu X; Wang W; Ye M; Yin H
    Plant J; 2023 May; 114(3):613-635. PubMed ID: 36799458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals.
    Liu X; Cai YD; Chiu JC
    J Biol Chem; 2024 Feb; 300(2):105616. PubMed ID: 38159854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFAT1/HBP/O-GlcNAcylation Axis Regulates
    Jia C; Li H; Fu D; Lan Y
    Biomed Res Int; 2020; 2020():1921609. PubMed ID: 32149084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
    Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
    PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
    Lam C; Low JY; Tran PT; Wang H
    Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
    Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
    Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
    Phillips RM; Lam C; Wang H; Tran PT
    Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexosamines, insulin resistance, and the complications of diabetes: current status.
    Buse MG
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
    Chatham JC; Nöt LG; Fülöp N; Marchase RB
    Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights: A role for O-GlcNAcylation in diabetic complications.
    Peterson SB; Hart GW
    Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of Arabidopsis
    Chen YH; Shen HL; Chou SJ; Sato Y; Cheng WH
    Front Plant Sci; 2022; 13():903272. PubMed ID: 35747876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.